Detalhe da pesquisa
1.
Organoid Modeling of the Tumor Immune Microenvironment.
Cell
; 175(7): 1972-1988.e16, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30550791
2.
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Nature
; 603(7903): 934-941, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130560
3.
CD81 costimulation skews CAR transduction toward naive T cells.
Proc Natl Acad Sci U S A
; 119(5)2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35091467
4.
Use of cardiac radiation therapy as bridging therapy to CAR-T for relapsed pediatric B-cell acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 68(3): e28870, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33355997
5.
T-Cell Immunopeptidomes Reveal Cell Subtype Surface Markers Derived From Intracellular Proteins.
Proteomics
; 18(12): e1700410, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29493099
6.
Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia.
Blood
; 138(21): 2138-2142, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34499715
7.
New developments in immunotherapy for pediatric solid tumors.
Curr Opin Pediatr
; 30(1): 30-39, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29189429
8.
INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies-Established Findings and Future Priorities.
Transplant Cell Ther
; 30(2): 155-170, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37863355
9.
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results.
Leukemia
; 38(5): 963-968, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38491306
10.
Targeted Mutational Profiling Reveals Clonal Relationships in Metachronous Occurrence of Classic Hodgkin and Mediastinal Large B-Cell Lymphomas.
Am J Surg Pathol
; 47(1): 81-90, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36001451
11.
INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic Leukemia.
Transplant Cell Ther
; 29(10): 598-607, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37481241
12.
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns.
EClinicalMedicine
; 65: 102268, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37954907
13.
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia.
J Clin Oncol
; 41(2): 354-363, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108252
14.
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.
Blood Adv
; 7(12): 2758-2771, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36857419
15.
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium.
Blood Adv
; 7(4): 541-548, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35938863
16.
Mediport use as an acceptable standard for CAR T cell infusion.
Front Immunol
; 14: 1239132, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965315
17.
Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy.
Blood Adv
; 6(7): 1961-1968, 2022 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788386
18.
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report.
Blood Adv
; 6(2): 600-610, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794180
19.
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.
J Clin Oncol
; 40(9): 945-955, 2022 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882493
20.
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia.
Blood Adv
; 6(14): 4251-4255, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580324